相关实验视频
Updated: Jun 8, 2025

Facile Preparation of 4-Substituted Quinazoline Derivatives
Published on: February 15, 2016
奎尔氨酸的治疗潜力:前景和进展
Harsh Yadav1, Rishabha Malviya1, Niranjan Kaushik1
1Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India.
奎尔素和相关化合物显示出对各种疾病,包括心血管和神经系统疾病的治疗前景. 由于生物可用性问题,需要进行进一步的临床试验来确认它们的有效性和安全性.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- 奎尔赛丁是一种具有抗氧化和抗炎性能的黄类化合物.
- 它的治疗潜力正在针对一系列健康状况进行探索.
- 与生物可用性和分布相关的挑战影响临床应用.
研究的目的:
- 调查奎尔丁和相关化合物的治疗潜力.
- 阐明它们的药理特征和作用的分子机制.
- 讨论它们对心血管,神经和代谢疾病的益处.
主要方法:
- 关于奎尔丁及其类型的现有研究的文献综述.
- 对药理学数据和分子机制的分析.
- 讨论临床疗效,生物可用性和分布方面的挑战.
主要成果:
- 奎尔和其类型对心血管健康,脑部疾病和代谢状况具有潜在的益处.
- 确定了多种作用机制,包括细胞信号通路和酶相互作用的调节.
- 由于生物可用性和分布限制,人们对临床疗效的担忧得到了强调.
结论:
- 奎尔和相关化合物在各种医学领域具有显著的治疗前景.
- 研究人员和临床医生之间的协作努力对于有效的治疗整合至关重要.
- 进一步的临床试验对于验证这些化合物的有效性和安全性至关重要.
更多相关视频
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
09:50Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade
Published on: August 14, 2019
相关概念视频
Gene Regulation in Microbial Communities: Quorum Sensing
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Cholinergic Antagonists: Pharmacokinetics